Mihaila, R. G., & Topircean, D. (2021). The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia. Palacký University Olomouc, Faculty of Medicine and Dentistry.
Cita Chicago Style (17a ed.)Mihaila, Romeo Gabriel, y Diana Topircean. The High-performance Technology CRISPR/Cas9 Improves Knowledge and Management of Acute Myeloid Leukemia. Palacký University Olomouc, Faculty of Medicine and Dentistry, 2021.
Cita MLA (8a ed.)Mihaila, Romeo Gabriel, y Diana Topircean. The High-performance Technology CRISPR/Cas9 Improves Knowledge and Management of Acute Myeloid Leukemia. Palacký University Olomouc, Faculty of Medicine and Dentistry, 2021.
Precaución: Estas citas no son 100% exactas.